11 loaded recalls began on this date. 0 Class I. 11 ongoing.
Drugs
Class II
Ongoing
Reported Sep 2, 2026
Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Ph...
Firm: ACCORD HEALTHCARE, INC.
Reason: Subpotent Drug
openFDA source record
Drugs
Class II
Ongoing
Reported Sep 2, 2026
Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pha...
Firm: ACCORD HEALTHCARE, INC.
Reason: Subpotent Drug
openFDA source record
Drugs
Class II
Ongoing
Reported Sep 2, 2026
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Ph...
Firm: ACCORD HEALTHCARE, INC.
Reason: Subpotent Drug
openFDA source record
Drugs
Class II
Ongoing
Reported Sep 2, 2026
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas P...
Firm: ACCORD HEALTHCARE, INC.
Reason: Subpotent Drug
openFDA source record
Drugs
Class II
Ongoing
Reported Sep 2, 2026
Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729-454-15) b) 1000-count bottles (NDC 16729-454-17), Rx Only, Manufactured...
Firm: ACCORD HEALTHCARE, INC.
Reason: Subpotent Drug
openFDA source record
Drugs
Class II
Ongoing
Reported Sep 2, 2026
Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Ph...
Firm: ACCORD HEALTHCARE, INC.
Reason: Subpotent Drug
openFDA source record
Drugs
Class II
Ongoing
Reported Sep 2, 2026
Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufacture...
Firm: ACCORD HEALTHCARE, INC.
Reason: Subpotent Drug
openFDA source record
Drugs
Class II
Ongoing
Reported Sep 2, 2026
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharm...
Firm: ACCORD HEALTHCARE, INC.
Reason: Subpotent Drug
openFDA source record
Drugs
Class II
Ongoing
Reported Sep 2, 2026
Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-871...
Firm: Mallinckrodt Hospital Products Inc.
Reason: Presence of particulate matter: glass and stopper piece
openFDA source record
Devices
Class II
Ongoing
Reported Sep 2, 2026
ORT200, operating room table, including the ORT200 Covered Table Assembly, Reconditioned, Part Number 113821-600 and the ORT200 50/60Hz Covered Table Assy V2 Part Number...
Firm: IMRIS Imaging Inc
Reason: The linear actuator and rotational lock mechanism components may experience a mechanical failure that prevents the system from transitioning between locked and unlocked state. This may pose a risk of injury to...
openFDA source record
Devices
Class II
Ongoing
Reported Sep 2, 2026
ORT300, operating room table, ORT300 Modular Table Main Unit Assy Part Numbers 114093-000 and 114093-600
Firm: IMRIS Imaging Inc
Reason: The linear actuator and rotational lock mechanism components may experience a mechanical failure that prevents the system from transitioning between locked and unlocked state. This may pose a risk of injury to...
openFDA source record